Skip to main content

Alert!

There has been an error in displaying this message. Please contact the site administrator.

News & Articles

UTHealth Houston Research

March 13, 2025
Written By: Kenny Bybee | Updated: March 13, 2025
UTHealth Houston continues to rank among the nation’s top institutions for National Institutes of Health (NIH) research funding, according to the latest annual rankings from the Blue Ridge Institute for Medical Research.
A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.
Five years after the first groundbreaking fetoscopic spina bifida repair surgery using an innovative patch pioneered by researchers at UTHealth Houston, the fetal medicine team is celebrating the more than 100 procedures performed by the physicians and the launch of the UTHealth Houston Fetal Institute.
Large and rare duplications and deletions in a chromosome region known as 22q11.2, which involves genes that regulate cardiac development, are linked to nonsyndromic bicuspid aortic valve disease, according to a new study led by UTHealth Houston researchers.
In an effort to close the gap in neurological outcomes for underserved populations, a UTHealth Houston project funded with $2.9 million from the National Institutes of Health (NIH) will engage community partners to improve the design of clinical trials.
New research led by UTHealth Houston scientists uncovered two genes associated with variants linked to epilepsy, which showed specific traits that make them promising diagnostic biomarkers. The study was recently published in Nature Communications.
A new UTHealth Houston study focused on finding the best surgical technique for reconstruction of the acromioclavicular joint (ACJ), where the collarbone meets the shoulder blade, has the potential to enhance recovery and long-term shoulder health for young athletes.
After graduating EMT school in 2014, Luke was fully prepared to take the call to help people and families in need. But one thing he didn’t prepare for was to be the one on the other end of the line asking for help.
A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the Institute of Psychiatry, Psychology & Neuroscience at King’s College London; and the University of East London.
October 10, 2024
Written By: Deborah Mann Lake | Updated: October 10, 2024
Ashley Hallock, 35, describes the day she joined a clinical trial studying stem cells for bipolar disorder as the most important day of her life. “For me, it was a godsend,” she said.